LONDON, May 23, 2023 Mereo BioPharma Group plc , a clinical-stage biopharmaceutical company focused on rare diseases today announced that data from the Phase 2 “ASTRAEUS” trial of. | May 23, 2023
Mereo BioPharma (MREO) Presents Phase 2 Data from ASTRAEUS Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LONDON, May 23, 2023 (GLOBE NEWSWIRE) Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical company.
Animal safety investigators and a veterinarian called by police to a Wilsonville home last year found dogs, cats, horses and a pig trapped in deplorable…